Abiopharma

C3.AI, INC. (AI)

Symbol	AI
Name	C3.AI, INC.
Sector	TECHNOLOGY
Region	North America
Industry	Computer Software: Prepackaged Software
Address	1300 SEAPORT BOULEVARD,SUITE 500, REDWOOD CITY, California, 94063, United States
Telephone	+1 650 503-2200
Fax	—
Email	—
Website	https://www.c3.ai
Incorporation	UNDEFINED
Incorporated On	—
Employees	—
Fiscal Year	—
Public Since	—
Exchanges	NASDAQ
Auditor	—
Audit Status	NOT PROVIDED
Reporting Status	—
CIK	—
Description	C3.ai Inc is an enterprise artificial intelligence company. The company provides software-as-a-service applications that enable customers to rapidly develop, deploy, and operate large-scale Enterprise AI applications across any infrastructure. It provides solutions under three divisions namely, The C3 AI Suite, is a comprehensive application development and runtime environment that is designed to allow customers to rapidly design, develop, and deploy Enterprise AI applications of any type; C3 AI Applications, include a large and growing family of industry-specific and application-specific turnkey AI solutions that can be immediately installed and deployed; and C3.ai Ex Machina, analytics for applying data science to every-day business decisions. Additional info from NASDAQ: C3.ai Inc is an enterprise artificial intelligence company. The company provides software-as-a-service applications that enable customers to rapidly develop, deploy, and operate large-scale Enterprise AI applications across any infrastructure. It provides solutions under three divisions namely, The C3 AI Suite, is a comprehensive application development and runtime environment that is designed to allow customers to rapidly design, develop, and deploy Enterprise AI applications of any type; C3 AI Applications, include a large and growing family of industry-specific and application-specific turnkey AI solutions that can be immediately installed and deployed; and C3.ai Ex Machina, analytics for applying data science to every-day business decisions.

2026-04-16 23:07

Director Hyten John E. 🔴 sold 2.5K shares of C3.ai, Inc. (AI) at $9.52 Transaction Date: Apr 15, 2026 | Filing ID: 000044

2026-04-15 22:00

Director SIEBEL THOMAS M 🟡 adjusted position in 491.5K shares (2 derivative) of C3.ai, Inc. (AI) at $8.49 ($6.1M) Transaction Date: Apr 13, 2026 | Filing ID: 000042

2026-04-08 13:00

C3 AI Announces C3 Code: The Enterprise AI Development Platform That Turns Natural Language Into Production-Grade Applications

2026-04-01 22:56

Ehikian Stephen Bradley 🟡 adjusted position in 20.1K shares of C3.ai, Inc. (AI) at $8.22 Transaction Date: Mar 30, 2026 | Filing ID: 000040

2026-04-01 22:48

Director Hyten John E. 🟡 adjusted position in 0 shares of C3.ai, Inc. (AI) Transaction Date: Mar 31, 2026 | Filing ID: 000038

2026-03-31 21:09

📋 Stephen Ehikian (Officer) plans to sell 52K shares of C3.ai Inc (at $8.22 each, total $429K) Filed: Mar 31, 2026 | ID: 022491

2026-03-27 20:15

📋 Jim H. Snabe (Director) plans to sell 10K shares of C3.AI, INC. (at $8.00 each, total $80K) Filed: Mar 27, 2026 | ID: 000002

2026-03-26 14:00

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of C3.ai, Inc. - AI

2026-03-19 20:05

Director SIEBEL THOMAS M 🟡 adjusted position in 501.5K shares (2 derivative) of C3.ai, Inc. (AI) at $8.86 ($6.4M) Transaction Date: Mar 17, 2026 | Filing ID: 000032

2026-03-19 14:00

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of C3.ai, Inc. - AI